BlackRock Health Sciences Trust shares have declined 12.4% in the past year, underperforming the broader market rally. BME currently trades at an 8.3% discount to NAV, significantly wider than its five-year average discount of 2.48%. Despite an attractive 8.6% dividend yield, BME's low net investment income raises concerns about the sustainability of its distributions.
Call writing closed-end funds can offer attractive monthly distributions, along with the opportunity to trade at discounts to their historical net asset values. That discount can create an opportunity for investors to enter at attractive prices while getting the underlying portfolio on 'sale.' Today, we are looking at two CEFs that provide monthly distributions and are presenting relatively att...
Market timing is futile; a disciplined, diversified, and rules-based approach is essential for long-term investing success. A Near-Perfect Strategy portfolio aims for consistent income, growth, and lower volatility through diversification and strategic planning. The portfolio targets 6% income and S&P 500-beating returns, with lower volatility and drawdowns, making it suitable for investors see...
The healthcare sector is attractive due to essential nature, AI, genomics, and chronic disease management, supporting long-term growth despite regulatory and cost headwinds. BlackRock Health Sciences Trust offers a resilient 8.63% dividend yield, low expense ratio, and conservative, low-risk positioning ideal for income-focused investors. BME's option strategy caps upside but provides steady in...
Healthcare CEFs are under pressure from regulatory shifts, but sector defensiveness and discounted valuations can create long-term opportunities. Within the CEF structure, we also have the added benefit that comes with the discount/premium dynamic inherent in the structure. We are looking at two names today that present investors with attractive distributions and that are looking like decently ...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.